Cepheid Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Combination Test
Share this article Share this article Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season SUNNYVALE, Calif., Jan. 14, 2021 /CNW/ -- Cepheid today announced that Health Canada has issued Cepheid a medical device license for Xpert ® Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample. The test is now available in Canada and can be used in laboratories and at the point of ca...
Source: newswire.ca